Literature DB >> 26979086

Moraxella catarrhalis decreases antiviral innate immune responses by down-regulation of TLR3 via inhibition of p53 in human bronchial epithelial cells.

Annina Heinrich1, Helge Haarmann2, Sabrina Zahradnik3, Katrin Frenzel4, Frauke Schreiber1, Tilman E Klassert1, Kerstin A Heyl1, Anne-Sophie Endres5, Michaela Schmidtke6, Jörg Hofmann4, Hortense Slevogt7.   

Abstract

Chronic obstructive pulmonary disease (COPD) is complicated by infectious exacerbations with acute worsening of respiratory symptoms. Coinfections of bacterial and viral pathogens are associated with more severe exacerbations. Moraxella catarrhalis is one of the most frequent lower respiratory tract pathogens detected in COPD. We therefore studied the impact of M. catarrhalis on the antiviral innate immune response that is mediated via TLR3 and p53. Molecular interactions between M. catarrhalis and normal human bronchial epithelial (NHBE) cells as well as Beas-2B cells were studied using flow cytometry, quantitative PCR analysis, chromatin immunoprecipitation, RNA interference, and ELISA. M. catarrhalis induces a significant down-regulation of TLR3 in human bronchial epithelial cells. In M. catarrhalis-infected cells, expression of p53 was decreased. We detected a reduced binding of p53 to the tlr3 promoter, resulting in reduced TLR3 gene transcription. M. catarrhalis diminished the TLR3-dependent secretion of IFN-β, IFN-λ, and chemokine (C-X-C motif) ligand 8. In addition in M. catarrhalis infected cells, expression of rhinovirus type 1A RNA was increased compared with uninfected cells. M. catarrhalis reduces antiviral defense functions of bronchial epithelial cells, which may increase susceptibility to viral infections.-Heinrich, A., Haarmann, H., Zahradnik, S., Frenzel, K., Schreiber, F., Klassert, T. E., Heyl, K. A., Endres, A.-S., Schmidtke, M., Hofmann, J., Slevogt, H. Moraxella catarrhalis decreases antiviral innate immune responses by down-regulation of TLR3 via inhibition of p53 in human bronchial epithelial cells. © FASEB.

Entities:  

Keywords:  COPD; bacterial colonization; lung cancer; tumor suppressor; viral infection

Mesh:

Substances:

Year:  2016        PMID: 26979086     DOI: 10.1096/fj.201500172R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

1.  A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by Toxoplasma Kinase ROP18.

Authors:  Zhaoshou Yang; Yongheng Hou; Taofang Hao; Hee-Sool Rho; Jun Wan; Yizhao Luan; Xin Gao; Jianping Yao; Aihua Pan; Zhi Xie; Jiang Qian; Wanqin Liao; Heng Zhu; Xingwang Zhou
Journal:  Mol Cell Proteomics       Date:  2017-01-13       Impact factor: 5.911

Review 2.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

3.  Evaluation of respiratory tract bacterial co-infections in SARS-CoV-2 patients with mild or asymptomatic infection in Lagos, Nigeria.

Authors:  Olabisi Flora Davies-Bolorunduro; Muinah Adenike Fowora; Olufemi Samuel Amoo; Esther Adeniji; Kazeem Adewale Osuolale; Oluwatobi Oladele; Tochukwu Ifeanyi Onuigbo; Josephine Chioma Obi; Joy Oraegbu; Oluwatobi Ogundepo; Rahaman Ademolu Ahmed; Olagoke AbdulRazaq Usman; Bosede Ganiyat Iyapo; Adedamola Adejuwon Dada; Ngozi Onyia; Richard Adebayo Adegbola; Rosemary Ajuma Audu; Babatunde Lawal Salako
Journal:  Bull Natl Res Cent       Date:  2022-04-21

Review 4.  Interrupting the Conversation: Implications for Crosstalk Between Viral and Bacterial Infections in the Asthmatic Airway.

Authors:  Jodie Ackland; Alastair Watson; Tom M A Wilkinson; Karl J Staples
Journal:  Front Allergy       Date:  2021-10-26

5.  A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD.

Authors:  Tom M A Wilkinson; Emmanuel Aris; Simon Bourne; Stuart C Clarke; Mathieu Peeters; Thierry G Pascal; Sonia Schoonbroodt; Andrew C Tuck; Viktoriya Kim; Kristoffer Ostridge; Karl J Staples; Nicholas Williams; Anthony Williams; Stephen Wootton; Jeanne-Marie Devaster
Journal:  Thorax       Date:  2017-04-21       Impact factor: 9.139

Review 6.  Insights Into Type I and III Interferons in Asthma and Exacerbations.

Authors:  Helen E Rich; Danielle Antos; Natalie R Melton; John F Alcorn; Michelle L Manni
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.